Penserra Capital Management LLC Bio Rad Laboratories, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $5,387 - $7,300	-20 Reduced 17.24%	96 $30,000
Q3 2023 Nov 15, 2023	SELL	$350.25 - $422.63 $8,406 - $10,143	-24 Reduced 17.14%	116 $41,000
Q2 2023 Aug 11, 2023	BUY	$359.49 - $486.4 $50,328 - $68,096	140 New	140 $53,000
Q2 2020 Aug 14, 2020	SELL	$334.87 - $493.06 $267,896 - $394,448	-800 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$320.01 - $409.07 $256,008 - $327,256	800 New	800 $365,000

478

19.2M

15.7K

11.5K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.43B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.